Sodium glucose co-transporter 2 (SGLT2) inhibitors: novel antidiabetic agents

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans

(2011) James F. List et al.   KIDNEY INTERNATIONAL

Effect of kidney disease on glucose handling (including genetic defects)

(2011) Joaquim Calado et al.   KIDNEY INTERNATIONAL

Glucose handling by the kidney

(2011) Amanda Mather et al.   KIDNEY INTERNATIONAL

SGLT2 inhibitors: molecular design and potential differences in effect

(2011) Masayuki Isaji   KIDNEY INTERNATIONAL

Renal glucose reabsorption inhibitors to treat diabetes

(2011) Clifford J. Bailey   TRENDS IN PHARMACOLOGICAL SCIENCES

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

(2010) Jian Chen et al.   Diabetes Therapy

Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug

(2009) Iskandar Idris et al.   DIABETES OBESITY & METABOLISM

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications

(2009) J. E. Gerich   DIABETIC MEDICINE

Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents

(2009) William N Washburn   EXPERT OPINION ON THERAPEUTIC PATENTS

Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2

(2009) William N. Washburn   JOURNAL OF MEDICINAL CHEMISTRY

Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2

(2008) Bruce A. Ellsworth et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS